Literature DB >> 18618079

How much do GOLD stages reflect CT abnormalities in COPD patients?

M Pescarolo1, N Sverzellati, A Verduri, A Chetta, E Marangio, M De Filippo, D Olivieri, M Zompatori.   

Abstract

PURPOSE: Severity of chronic obstructive pulmonary disease (COPD) can be graded using the classification released in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) report. Such classification is essentially based on spirometry and does not recognise the role of other measures. The aim of this study was to assess whether the GOLD stages correlate with the extent of pulmonary emphysema and other ancillary computed tomography CT features in a population of smokers with stable COPD.
MATERIALS AND METHODS: Based on clinical assessment and lung-function testing, patients were classified according to the GOLD criteria. CT scans were visually evaluated for extent of emphysema and airway abnormalities.
RESULTS: A total of 43 patients were enrolled. The amount of emphysema was described as minimal in six patients with stage 0, and as moderate in seven patients with stage 0. In stages I and II, the extent of emphysema ranged from minimal to severe, whereas we observed the presence of severe emphysema in most patients in stages III and IV. According to the regression model, only CT emphysema extent independently predicted the GOLD stage (r2 = 0.58; p < 0.001). The cutoff value of emphysema extent of 31.5% allowed us to distinguish patients with a GOLD stage > or = III.
CONCLUSIONS: Although we found a significant correlation between CT emphysema extent and GOLD stages, different percentage of emphysema extent can be observed among each GOLD stage. The upper limit of 31.5% of emphysema extent may indicate a boundary for a clinically worsening status.

Entities:  

Mesh:

Year:  2008        PMID: 18618079     DOI: 10.1007/s11547-008-0284-3

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  37 in total

1.  Chest computed tomography: is it ready for major studies of chronic obstructive pulmonary disease?

Authors:  M G Cosio; G L Snider
Journal:  Eur Respir J       Date:  2001-06       Impact factor: 16.671

2.  Optimized scanning conditions of high resolution CT in the follow-up of pulmonary emphysema.

Authors:  M Mishima; H Itoh; H Sakai; Y Nakano; S Muro; T Hirai; Y Takubo; K Chin; M Ohi; K Nishimura; K Yamaguchi; T Nakamura
Journal:  J Comput Assist Tomogr       Date:  1999 May-Jun       Impact factor: 1.826

3.  Usefulness of GOLD classification of COPD severity.

Authors:  D Köhler; J Fischer; F Raschke; B Schönhofer
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

4.  Role of quantitative CT in predicting hypoxemia and complications after lung lobectomy for cancer, with special reference to area of emphysema.

Authors:  Kazuhiro Ueda; Yoshikazu Kaneda; Manabu Sudoh; Jinbo Mitsutaka; Nobuyuki Tanaka; Kazuyoshi Suga; Kimikazu Hamano
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

5.  Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT.

Authors:  A Dirksen; M Friis; K P Olesen; L T Skovgaard; K Sørensen
Journal:  Acta Radiol       Date:  1997-09       Impact factor: 1.990

6.  Imaging of emphysema and lung volume reduction surgery.

Authors:  E A Kazerooni; R I Whyte; A Flint; F J Martinez
Journal:  Radiographics       Date:  1997 Jul-Aug       Impact factor: 5.333

7.  Reliability of quantitative computed tomography to predict postoperative lung function in patients with chronic obstructive pulmonary disease having a lobectomy.

Authors:  Nicola Sverzellati; Alfredo Chetta; Elisa Calabrò; Paolo Carbognani; Eveline Internullo; Dario Olivieri; Maurizio Zompatori
Journal:  J Comput Assist Tomogr       Date:  2005 Nov-Dec       Impact factor: 1.826

Review 8.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

9.  The 6-min walk distance: change over time and value as a predictor of survival in severe COPD.

Authors:  V M Pinto-Plata; C Cote; H Cabral; J Taylor; B R Celli
Journal:  Eur Respir J       Date:  2004-01       Impact factor: 16.671

10.  "Density mask". An objective method to quantitate emphysema using computed tomography.

Authors:  N L Müller; C A Staples; R R Miller; R T Abboud
Journal:  Chest       Date:  1988-10       Impact factor: 9.410

View more
  7 in total

1.  Density-based MDCT quantification of lobar lung volumes: a study of inter- and intraobserver reproducibility.

Authors:  F Molinari; M Amato; M Stefanetti; G Parapatt; A Macagnino; G Serricchio; T Pirronti; L Bonomo
Journal:  Radiol Med       Date:  2010-02-22       Impact factor: 3.469

2.  Forced expiratory capnography and chronic obstructive pulmonary disease (COPD).

Authors:  Robert H Brown; Allison Brooker; Robert A Wise; Curt Reynolds; Claudio Loccioni; Adolfo Russo; Terence H Risby
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

3.  Saber-sheath trachea as a marker of severe airflow obstruction in chronic obstructive pulmonary disease.

Authors:  Federica Ciccarese; Antonio Poerio; Silvia Stagni; Domenico Attinà; Luca Fasano; Paolo Carbonara; Maria Letizia Bacchi Reggiani; Maurizio Zompatori
Journal:  Radiol Med       Date:  2013-12-03       Impact factor: 3.469

4.  Optimal threshold in CT quantification of emphysema.

Authors:  Zhimin Wang; Suicheng Gu; Joseph K Leader; Shinjini Kundu; John R Tedrow; Frank C Sciurba; David Gur; Jill M Siegfried; Jiantao Pu
Journal:  Eur Radiol       Date:  2012-11-01       Impact factor: 5.315

5.  Cross-sectional analysis of the utility of pulmonary function tests in predicting emphysema in ever-smokers.

Authors:  Sean E Hesselbacher; Robert Ross; Matthew B Schabath; E O'Brian Smith; Sarah Perusich; Nadia Barrow; Pamela Smithwick; Manoj J Mammen; Harvey Coxson; Natasha Krowchuk; David B Corry; Farrah Kheradmand
Journal:  Int J Environ Res Public Health       Date:  2011-04-29       Impact factor: 3.390

6.  In Vivo Computed Tomography as a Research Tool to Investigate Asthma and COPD: Where Do We Stand?

Authors:  Gaël Dournes; Michel Montaudon; Patrick Berger; François Laurent
Journal:  J Allergy (Cairo)       Date:  2012-01-11

7.  Diagnostic and interventional radiology: an update.

Authors:  Andrea Giovagnoni; Massimo De Filippo; Antonio Barile
Journal:  Acta Biomed       Date:  2020-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.